Speciality: All Speciality
Description:
A warm welcome to all the medical professionals in this interesting session on The game changing DTP Combination Vaccine evolution to improve VCR.
The DTP (Diphtheria, Tetanus, and Pertussis) combination vaccine has been a cornerstone of childhood immunization programs worldwide. Its evolution marks significant advancements in improving vaccine coverage rates (VCR), ensuring broader protection against these serious infectious diseases.
Over the years, the DTP vaccine has undergone several modifications to enhance its efficacy and safety. Initially, whole-cell pertussis vaccines were used, which, although effective, were associated with higher rates of adverse reactions. The development of acellular pertussis vaccines (DTaP) offered a safer alternative with fewer side effects, leading to increased acceptance and higher vaccination rates.
Research is being conducted to develop next-generation vaccines that offer even broader protection with fewer doses. Additionally, efforts to educate communities and address vaccine hesitancy are essential to further improve VCR and sustain the gains achieved in controlling these preventable diseases.
Therefore, get an overall knowledge of the game changing DTP combination vaccine evolution to improve VCR.
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation